Citizen's Briefing Book

LAWSUIT FILED: Block & Leviton LLP Has Filed a Lawsuit Against Reata Pharmaceuticals, Inc. for Securities Fraud, Expanding the Class Period

Retrieved on: 
Friday, January 21, 2022
Alport syndrome, Alport, District council, Advisory Committee, NASDAQ, GLOBE, Citizen's Briefing Book, Chronic kidney disease, Therapy, Certification, FDA, Complaint, Reata Pharmaceuticals, Pharmaceutical industry, Online gambling

The complaint expands the class period that was asserted in a previously filed related securities class action pending against Reata captioned Doyle v. Reata Pharmaceuticals, Inc., No.

Key Points: 
  • The complaint expands the class period that was asserted in a previously filed related securities class action pending against Reata captioned Doyle v. Reata Pharmaceuticals, Inc., No.
  • ), and is brought on behalf of investors that incurred damages on their purchases in Reata common stock between November 14, 2016 and December 6, 2021, inclusive (the Class Period).
  • A class has not yet been certified, and until certification occurs, you are not represented by an attorney.
  • Block & Leviton LLP is a firm dedicated to representing investors and maintaining the integrity of the countrys financial markets.